An analogy can be made to the context of prostate cancer screening, in which patients referred to advanced testing, e.g., biopsy, based on elevated plasma prostate-specific antigen levels need not only to have the presence of a neoplastic formation confirmed but also characterized based on prognostically relevant histopathological features34. The gene discussed is KLK3; the disease is prostate carcinoma.